This site is intended for health professionals only

Home / News / Latest News / NHS England confirms funding for 160 more practice pharmacists

NHS England confirms funding for 160 more practice pharmacists

burnout NHS social care

11 Jan 2018

NHS England has approved funding for further 160 surgery-based pharmacist posts.

It means that the total of clinical pharmacists working across more than 3,200 GP practices will increase from around 580 to more than 1,100, covering a population of nearly 34 million patients.

A pilot programme to get pharmacists to work in general practice was initially launched in July 2015 but after a few months, funding rose from the initial £15m to £31m, which benefited around 700 practices.

Given the popularity of the programme, a new central investment of £112m was implemented with the General Practice Forward View (GPFV), to guarantee those practices initially not in the pilot would benefit from the scheme. The programme is set to bring a further 1,500 pharmacists in general practice by 2020.

Practices that have a clinical pharmacist allow their GPs to spend more time dealing with patients with greatest needs.

According to a NHS England case study, one practice in Devon managed to reduce the need for GP appointments by 30% and save around 400 hours of GP time per year by having a clinical pharmacist on site.

GP and NHS England director of primary care Dr Arvind Madan said: ‘The clinical pharmacist programme has proven to be a hugely popular with practices, patients and pharmacists themselves.

‘Clinical pharmacists have a wealth of knowledge and skills to offer great patient care, in a more convenient way and are also taking some of the pressure off GPs, particularly at this time of year when we know demand is even greater than usual.’


Want news like this straight to your inbox?


Latest News

Plans to allow pharmacists to administer Covid-19 vaccine become law
Community pharmacists will be able to administer Covid-19 vaccines under amendments to the Human Medicines...
Serious shortage protocol for Fluoxetine 40mg capsules ends
The serious shortage protocol (SSP) issued in response to ‘significant ongoing disruption to the supply...
Plans to withdraw widely-used bipolar drug put on hold
A drug company that recently increased the price of a bipolar drug, while also proposing...